Evidence map›Paper›PMID 37022767›Full record

ArticleeLife2023

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.

Carolyn Nickson, Megan A Smith, Eleonora Feletto, Louiza S Velentzis, Kate Broun, Sabine Deij, Paul Grogan, Michaela Hall, Emily He, D James St John and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Carolyn NicksonDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.ORCID 0000-0001-5370-6590
Megan A SmithDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Eleonora FelettoDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Louiza S VelentzisDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.ORCID 0000-0002-9309-0492
Kate BrounPrevention Division, Cancer Council Victoria, Melbourne, Australia.
Sabine DeijDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Paul GroganDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Michaela HallDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Emily HeDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
D James St JohnPrevention Division, Cancer Council Victoria, Melbourne, Australia.
Jie-Bin LewDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.ORCID 0000-0003-2837-3565
Pietro ProcopioDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Kate T SimmsDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
Joachim WorthingtonDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.ORCID 0000-0002-8830-0520
G Bruce MannBreast Service, The Royal Women's and Royal Melbourne Hospital, Melbourne, Australia.
Karen CanfellDaffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
The University of Sydney · AUThe Royal Melbourne Hospital · AUCancer Council Victoria · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Australia introduced COVID-19 infection prevention and control measures in early 2020. To help prepare health services, the Australian Government Department of Health commissioned a modelled evaluation of the impact of disruptions to population breast, bowel, and cervical cancer screening programmes on cancer outcomes and cancer services. We used the

Indexed as

Breast NeoplasmsColorectal NeoplasmsCOVID-19Uterine Cervical NeoplasmsAustraliaEarly Detection of CancerFemaleHumansbreast cancercancer screeningcervical cancercolorectal cancerCOVID-19epidemiologyglobal health

Identifiers

PMID37022767
PMCPMC10079286
OpenAlexW4362657365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.